Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul Torres-Ruiz

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|October 26, 2024
ddPCR Overcomes the CRISPR-Cas13a-Based Technique for the Detection of the BRAF p.V600E Mutation in Liquid BiopsiesIrina Palacín-Aliana, Noemí García-Romero, Josefa Carrión-Navarro, et al.
Stem Cell Reports|May 13, 2017
Efficient Recreation of t(11;22) EWSR1-FLI1<sup>+</sup> in Human Stem Cells Using CRISPR/Cas9Raul Torres-Ruiz, Marta Martinez-Lage, Maria C Martin, et al.
Molecular Therapy. Nucleic Acids|March 15, 2020
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem CellsPaolo Petazzi, Raul Torres-Ruiz, Antonella Fidanza, et al.
Communications Biology|July 30, 2024
Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphataseÁlvaro Gómez-Morón, Sergio Alegre-Gómez, Rocio Ramirez-Muñoz, et al.
Haematologica|January 26, 2019
Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between <i>AF4-MLL</i> and <i>MLL-AF4</i> fusionsClara Bueno, Fernando J Calero-Nieto, Xiaonan Wang, et al.
Molecular Therapy. Methods & Clinical Development|November 17, 2025
Harnessing DNA barcoding to enhance and sustain polyclonality in gene-edited hematopoietic stem cellsIsabel Ojeda-Perez, Andrés Bustos, Sridhar Selvaraj, et al.
Nature Communications|July 2, 2025
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progressionRuba Almaghrabi, Yara Alyahyawi, Peter Keane, et al.
Blood|September 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic featuresClara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez, et al.
EMBO Molecular Medicine|November 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutationsIrene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey, et al.
Gut|March 9, 2022
A faecal microbiota signature with high specificity for pancreatic cancerEce Kartal, Thomas S B Schmidt, Esther Molina-Montes, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|October 26, 2024
ddPCR Overcomes the CRISPR-Cas13a-Based Technique for the Detection of the BRAF p.V600E Mutation in Liquid BiopsiesIrina Palacín-Aliana, Noemí García-Romero, Josefa Carrión-Navarro, et al.
Stem Cell Reports|May 13, 2017
Efficient Recreation of t(11;22) EWSR1-FLI1<sup>+</sup> in Human Stem Cells Using CRISPR/Cas9Raul Torres-Ruiz, Marta Martinez-Lage, Maria C Martin, et al.
Molecular Therapy. Nucleic Acids|March 15, 2020
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem CellsPaolo Petazzi, Raul Torres-Ruiz, Antonella Fidanza, et al.
Communications Biology|July 30, 2024
Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphataseÁlvaro Gómez-Morón, Sergio Alegre-Gómez, Rocio Ramirez-Muñoz, et al.
Haematologica|January 26, 2019
Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between <i>AF4-MLL</i> and <i>MLL-AF4</i> fusionsClara Bueno, Fernando J Calero-Nieto, Xiaonan Wang, et al.
Molecular Therapy. Methods & Clinical Development|November 17, 2025
Harnessing DNA barcoding to enhance and sustain polyclonality in gene-edited hematopoietic stem cellsIsabel Ojeda-Perez, Andrés Bustos, Sridhar Selvaraj, et al.
Nature Communications|July 2, 2025
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progressionRuba Almaghrabi, Yara Alyahyawi, Peter Keane, et al.
Blood|September 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic featuresClara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez, et al.
EMBO Molecular Medicine|November 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutationsIrene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey, et al.
Gut|March 9, 2022
A faecal microbiota signature with high specificity for pancreatic cancerEce Kartal, Thomas S B Schmidt, Esther Molina-Montes, et al.
Pageof 3